Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies von VAN NES, S. I, VANHOUTTE, E. K, VAN DOORN, P. A, HERMANS, M, BAKKERS, M, KUITWAARD, K, FABER, C. G, MERKIES, I. S. J

Volltext

European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience von Ploeg, A. T., Kruijshaar, M. E., Toscano, A., Laforêt, P., Angelini, C., Lachmann, R. H., Pascual Pascual, S. I., Roberts, M., Rösler, K., Stulnig, T., Doorn, P. A., Van den Bergh, P. Y. K., Vissing, J., Schoser, B., Bembi, Bruno, Broomfield, Alexander, Boentert, Matthias, Desnuelle, Claude, Findling, Oliver, Hahn, Andreas, Díaz‐Manera, Jordi, Hundsberger, Thomas, Kornblum, Cornelia, Labarthé, Franҫois, Laforet, Pascal, Mengel, Karl‐Eugen, Mongini, Tiziana, Muller‐Felber, Wolfgang, Parenti, Giancarlo, Pijnappel, W. Pim, Preisler, Nicolai, Sacconi, Sabrina, Talim, Beril, Tardieu, Marine, Beek, Nadine A.M.E, Wenninger, Stephan

Volltext

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task... von Van den Bergh, P. Y. K., Hadden, R. D. M., Bouche, P., Cornblath, D. R., Hahn, A., Illa, I., Koski, C. L., Léger, J.-M., Nobile-Orazio, E., Pollard, J., Sommer, C., Van Doorn, P. A., Van Schaik, I. N.

Volltext

Early recognition of poor prognosis in Guillain-Barré syndrome von WALGAARD, C, LINGSMA, H. F, RUTS, L, VAN DOORN, P. A, STEYERBERG, E. W, JACOBS, B. C

Volltext

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG - the ICE study von Vanhoutte, E. K., Latov, N., Deng, C., Hanna, K., Hughes, R. A. C., Bril, V., Dalakas, M. C., Donofrio, P., van Doorn, P. A., Hartung, H.-P., Merkies, I. S. J.

Volltext

Pain in Guillain-Barré syndrome: A long-term follow-up study von RUTS, L, DRENTHEN, J, JONGEN, J. L. M, HOP, W. C. J, VISSER, G. H, JACOBS, B. C, VAN DOORN, P. A

Volltext

Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment von EFTIMOV, F, VERMEULEN, M, VAN DOORN, P. A, BRUSSE, E, VAN SCHAIK, I. N

Volltext

Distinguishing acute-onset CIDP from fluctuating Guillain-Barré syndrome: A prospective study von RUTS, L, DRENTHEN, J, JACOBS, B. C, VAN DOOM, P. A

Volltext

Reply to the Letter to the Editor “Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?” by Kokubun N. et al von Bergh, P. Y. K., Doorn, P. A., Hadden, R. D. M.

Volltext

Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning von Dorpel, J. J. A., Mackenbach, M. J., Dremmen, M. H. G., Vlugt, W. M. C., Rizopoulos, D., Doorn, P. A., Ploeg, A. T., Muetzel, R., Beek, N. A. M. E., Hout, J. M. P.

Volltext

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy von CATS, E. A, VAN DER POL, W.-L, WOKKE, J. H, VELDINK, J. H, VAN DEN BERG, L. H, PIEPERS, S, FRANSSEN, H, JACOBS, B. C, VAN DEN BERG-VOS, R. M, KUKS, J. B, VAN DOORN, P. A, VAN ENGELEN, B. G, VERSCHUUREN, J. J

Volltext

Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients von Hagemans, M. L. C., Winkel, L. P. F., Van Doorn, P. A., Hop, W. J. C., Loonen, M. C. B., Reuser, A. J. J., Van der Ploeg, A. T.

Volltext

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy von Kuitwaard, K., Brusse, E., Jacobs, B. C., Vrancken, A. F. J. E., Eftimov, F., Notermans, N. C., Kooi, A. J., Fokkink, W. ‐J. R., Nieboer, D., Lingsma, H. F., Merkies, I. S. J., Doorn, P. A.

Volltext

Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients von van den Dorpel, J. J. A., Poelman, E., Harlaar, L., van Kooten, H. A., van der Giessen, L. J., van Doorn, P. A., van der Ploeg, A. T., van den Hout, J. M. P., van der Beek, N. A. M. E.

Volltext

Clinical outcome of CIDP one year after start of treatment: a prospective cohort study von Bus, S. R. M., Broers, M. C., Lucke, I. M., Bunschoten, C., van Lieverloo, G. G. A., Adrichem, M. E., van Veen, R., Wieske, L., Lingsma, H. F., Goedee, H. S., van der Pol, W. L., van Schaik, I. N., Van Doorn, P. A., Jacobs, B. C., Eftimov, F.

Volltext

Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies von Draak, T. H. P., Gorson, K. C., Vanhoutte, E. K., van Nes, S. I., van Doorn, P. A., Cornblath, D. R., van den Berg, L. H., Faber, C. G., Merkies, I. S. J.

Volltext

The natural course of non-classic Pompe's disease; a review of 225 published cases von WINKEL, Eon P. F, HAGEMANS, Marloes L. C, VAN DOORN, Pieter A, LOONEN, M. Christa B, HOP ARNOLD, Wim J. C, REUSER, J. J, VAN DER PLOEG, Ans T

Volltext

Prospective study on the relationship between infections and multiple sclerosis exacerbations von BULJEVAC, D, FLACH, H. Z, HOP, W. C. J, HIJDRA, D, LAMAN, J. D, SAVELKOUL, H. F. J, VAN DER MECHE, F. G. A, VAN DOORN, P. A, HINTZEN, R. Q

Volltext

Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy von van Gelder, C. M., van Capelle, C. I., Ebbink, B. J., Moor-van Nugteren, I., van den Hout, J. M. P., Hakkesteegt, M. M., van Doorn, P. A., de Coo, I. F. M., Reuser, A. J. J., de Gier, H. H. W., van der Ploeg, A. T.

Volltext

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task... von Hughes, R. A. C., Bouche, P., Cornblath, D. R., Evers, E., Hadden, R. D. M., Hahn, A., Illa, I., Koski, C. L., Léger, J. M., Nobile-Orazio, E., Pollard, J., Sommer, C., Van den Bergh, P., Van Doorn, P. A., Van Schaik, I. N.

Volltext